A five year long research on insulin glargine and NPH treatment has been conducted in Sanofi-aventis, to observe the effectivity of these treatments in retinopathy which has been the major cause of blindness in diabetics. The study revealed glargine to be more effective than NPH.
WASHINGTON - A natural compound can be used to stop diabetic retinopathy, one of the leading causes of blindness around the world, according to researchers at the University of Oklahoma Health Sciences Center.
WASHINGTON - Harold Hamm Oklahoma Diabetes Center researchers have found a link between taking vitamin C with insulin and stopping blood vessel damage caused by type 1 diabetes.
WASHINGTON - South Asians with type 2 diabetes are more likely to lose their eyesight at an earlier age compared to White Europeans with the same condition, according to a new study.
WASHINGTON - People at risk of becoming blind can now be screened almost instantaneously for eye diseases like diabetic retinopathy and age-related macular degeneration.